2/26
04:14 pm
bmy
Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights [Yahoo! Finance]
Low
Report
Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights [Yahoo! Finance]
2/26
11:23 am
bmy
Bristol Myers Squibb (BMY) is a Top-Ranked Momentum Stock: Should You Buy? [Yahoo! Finance]
Low
Report
Bristol Myers Squibb (BMY) is a Top-Ranked Momentum Stock: Should You Buy? [Yahoo! Finance]
2/26
07:24 am
bmy
SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer [Yahoo! Finance]
Low
Report
SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer [Yahoo! Finance]
2/26
06:59 am
bmy
SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
Low
Report
SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer
2/26
06:27 am
bmy
Bristol Myers Squibb (BMY) was upgraded by Royal Bank Of Canada to "hold".
Low
Report
Bristol Myers Squibb (BMY) was upgraded by Royal Bank Of Canada to "hold".
2/25
10:28 pm
bmy
Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow [Yahoo! Finance]
Low
Report
Earnings To Watch: Amneal (AMRX) Reports Q4 Results Tomorrow [Yahoo! Finance]
2/25
10:12 am
bmy
Large cap pharma defensive AI winner, says RBC as it backs Lilly & AbbVie [Yahoo! Finance]
Low
Report
Large cap pharma defensive AI winner, says RBC as it backs Lilly & AbbVie [Yahoo! Finance]
2/24
06:04 pm
bmy
Bristol Myers Squibb (BMY) is now covered by Royal Bank Of Canada. They set a "sector perform" rating on the stock.
Low
Report
Bristol Myers Squibb (BMY) is now covered by Royal Bank Of Canada. They set a "sector perform" rating on the stock.
2/24
10:23 am
bmy
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]
Low
Report
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]
2/24
12:21 am
bmy
Assessing Bristol Myers Squibb (BMY) Valuation After Key Multiple Myeloma And Alpha Thalassemia Updates [Yahoo! Finance]
Low
Report
Assessing Bristol Myers Squibb (BMY) Valuation After Key Multiple Myeloma And Alpha Thalassemia Updates [Yahoo! Finance]
2/23
04:38 pm
bmy
Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/23
04:16 pm
bmy
Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference
Low
Report
Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference
2/23
07:17 am
bmy
Bristol Myers Squibb (NYSE:BMY) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Bristol Myers Squibb (NYSE:BMY) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
2/23
06:59 am
bmy
Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (a)-Thalassemia
Low
Report
Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (a)-Thalassemia
2/21
02:32 pm
bmy
Down 25%, Should You Buy the Dip on Bristol Myers Squibb? [Yahoo! Finance]
Low
Report
Down 25%, Should You Buy the Dip on Bristol Myers Squibb? [Yahoo! Finance]
2/21
06:31 am
bmy
Bristol Myers Squibb (NYSE:BMY) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Low
Report
Bristol Myers Squibb (NYSE:BMY) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
2/20
11:42 am
bmy
Dr. Reddy's biosimilar for Bristol's Orencia undergoes FDA review [Seeking Alpha]
Low
Report
Dr. Reddy's biosimilar for Bristol's Orencia undergoes FDA review [Seeking Alpha]
2/19
08:01 pm
bmy
Bristol Myers Squibb (NYSE:BMY) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Low
Report
Bristol Myers Squibb (NYSE:BMY) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
2/19
04:13 pm
bmy
Bristol-Myers: I'm Buying Post Earnings [Seeking Alpha]
Low
Report
Bristol-Myers: I'm Buying Post Earnings [Seeking Alpha]
2/19
11:32 am
bmy
Bristol-Myers Squibb: Oncology Franchise Remains A Core Strength [Seeking Alpha]
Low
Report
Bristol-Myers Squibb: Oncology Franchise Remains A Core Strength [Seeking Alpha]
2/17
05:31 pm
bmy
Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight
Low
Report
Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight
2/17
05:31 pm
bmy
Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight
Low
Report
Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight
2/17
06:59 am
bmy
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma
Low
Report
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma
2/13
02:31 pm
bmy
Bristol-Myers Squibb Company (BMY) Growth Portfolio Driving Earnings Growth [Yahoo! Finance]
Low
Report
Bristol-Myers Squibb Company (BMY) Growth Portfolio Driving Earnings Growth [Yahoo! Finance]
2/13
02:03 pm
bmy
The top-performing pharma and biotech stocks as group sees resurgence [Seeking Alpha]
Neutral
Report
The top-performing pharma and biotech stocks as group sees resurgence [Seeking Alpha]